Medpace Holdings Inc. (MEDP)
NASDAQ
Closed
Aug 24, 2026
Day's Range
610.1452 wk Range
373.00Overview - MEDP - Medpace Holdings Inc.
Key Statistics
Valuation
Enterprise Value
16.96B
P/E (Trailing)
‪36.40‬
P/E (Forward)
‪32.07‬
PEG Ratio
‪1.00‬
Price / Sales (TTM)
‪6.21‬
Price / Book
‪39.84‬
EV / EBITDA
‪27.76‬
Profitability
Gross Margin
‪28.50%‬
Profit Margin
‪17.66%‬
Operating Margin
‪20.75%‬
Return on Assets
‪20.09%‬
Return on Equity
‪162.15%‬
Ownership
Shares Outstanding
27.91M
Float
22.43M
Short % of Shares Outstanding
‪7.80%‬
Held by Insiders
‪19.70%‬
Held by Institutions
‪91.51%‬
Price stats
Beta
‪1.15‬
50-Day Avg
‪548.67‬
200-Day Avg
‪520.37‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
13 analysts
Average price target
‪$ 581.83‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MEDP - Medpace Holdings Inc.
Peers - MEDP - Medpace Holdings Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- MEDPNASDAQMedpace Holdings Inc.17.32BMarket Cap+24.80%52-week change35.96P/E (Trailing)‪17.66%‬Profit Margin
- NTRANASDAQNATERA INC (Common Stock) – ticker 45E47.86BMarket Cap+50.33%52-week change-215.11P/E (Trailing)‪-7.10%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.43.87BMarket Cap-15.16%52-week change39.06P/E (Trailing)‪25.03%‬Profit Margin
- ILMNNASDAQIllumina, Inc.33.12BMarket Cap+54.58%52-week change41.01P/E (Trailing)‪18.33%‬Profit Margin
- GHNASDAQGuardant Health Inc.22.90BMarket Cap+63.75%52-week change-51.42P/E (Trailing)‪-38.32%‬Profit Margin
- ICICLRNASDAQICON plc13.28BMarket Cap+0.02%52-week change264.97P/E (Trailing)‪0.32%‬Profit Margin
- RDNTNASDAQRadNet Inc.6.04BMarket Cap+9.41%52-week change1425.75P/E (Trailing)‪-0.93%‬Profit Margin
Profile Summary - MEDP - Medpace Holdings Inc.
About
Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehensive clinical development support across phases I through IV,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
